Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Federal Trade Commission
Cerilliant
Mallinckrodt
Cipla
QuintilesIMS
Teva
Daiichi Sankyo
Harvard Business School

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,840,722

« Back to Dashboard

Summary for Patent: 5,840,722
Title: Use of carboxylic acid derivatives as drugs
Abstract:A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I ##STR1##
Inventor(s): Baumann; Ernst (Dudenhofen, DE), Vogelbacher; Uwe Josef (Ludwigshafen, DE), Rheinheimer; Joachim (Ludwigshafen, DE), Klinge; Dagmar (Heidelberg, DE), Riechers; Hartmut (Ludwigshafen, DE), Kroger; Burkhard (Limburgerhof, DE), Bialojan; Siegfried (Oftersheim, DE), Bollschweiler; Claus (Heidelberg, DE), Wernet; Wolfgang (Hassloch, DE), Unger; Liliane (Ludwigshafen, DE), Raschack; Manfred (Weisenheim, DE)
Assignee: BASF Aktiengesellschaft (Ludwigshafen, DE)
Application Number:08/718,377
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,840,722

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,840,722

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany44 11 225.4Mar 31, 1994
PCT Information
PCT FiledMarch 23, 1995PCT Application Number:PCT/EP95/01099
PCT Publication Date:October 12, 1995PCT Publication Number: WO95/26716

International Patents Family Members for US Patent 5,840,722

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1070701 ➤ Try a Free Trial
Czech Republic 9602873 ➤ Try a Free Trial
Czech Republic 290684 ➤ Try a Free Trial
Germany 4411225 ➤ Try a Free Trial
Germany 59509537 ➤ Try a Free Trial
Denmark 0752854 ➤ Try a Free Trial
European Patent Office 0752854 ➤ Try a Free Trial
Spain 2162916 ➤ Try a Free Trial
Finland 963885 ➤ Try a Free Trial
Finland 118589 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Harvard Business School
Express Scripts
Accenture
Moodys
Fuji
Cipla
AstraZeneca
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot